| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
cir-ZNF609 / circular RNA ZNF609 / circRNA ZNF609 |
Hirschsprung disease |
ZNF609 |
miR-150-5p |
Q
| DN |
More |
| Human |
hsa_circ_ZNF609 |
- |
- |
diabetic retinopathy |
ZNF609 |
miR-615-5p |
Q
| DS |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
lupus nephritis |
ZNF609 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
- |
breast cancer |
ZNF609 |
miR-145-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
rhabdomyosarcoma |
ZNF609 |
- |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
myotonic dystrophy type 1 |
ZNF609 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
colorectal cancer |
ZNF609 |
- |
Q
| DN |
More |
| Human |
hsa_circ_ZNF609 |
- |
cZNF609 |
peripheral arterial disease |
ZNF609 |
- |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
- |
nasopharyngeal carcinoma |
ZNF609 |
miR-188 |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
lung adenocarcinoma |
ZNF609 |
miR-1224-3p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circZNF609 |
hepatocellular carcinoma |
ZNF609 |
miR-15a-5p, miR-15b-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circZNF609 |
coronary artery disorder |
ZNF609 |
hsa-miR-145-5p, hsa-miR-615-5p, hsa-miR-138-5p, hsa-miR-150-5p |
Q
| DN |
More |
| Human |
hsa_circ_ZNF609 |
- |
CircZNF609 |
hepatocellular carcinoma |
ZNF609 |
miR-324-3p |
Q
H
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
prostate cancer |
- |
miR-501-3p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
- |
colorectal cancer |
ZNF609 |
- |
Q
B
S
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circZNF609 |
non-small cell lung carcinoma |
ZNF609 |
miR-623 |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circRNA ZNF609 |
cervical cancer |
ZNF609 |
miR-197-3p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circRNA ZNF609 |
nasopharyngeal carcinoma |
ZNF609 |
miR-145 |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circRNA RNA ZNF609 |
glioma |
ZNF609 |
miR-1224-3p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
gastric cancer |
ZNF609 |
- |
Q
S
M
| DN |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
melanoma |
ZNF609 |
miR-138-5p |
Q
| UN |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circ_0000615 |
breast cancer |
ZNF609 |
- |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circular RNA ZNF609 |
glioma |
ZNF609 |
miR-378b |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circ-ZNF609 |
cholangiocarcinoma |
ZNF609 |
miR-432-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
focal segmental glomerulosclerosis |
ZNF609 |
miR-615-5p |
Q
H
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
Circular RNA zinc finger protein 609 |
nasopharyngeal carcinoma |
ZNF609 |
miR-338-3p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circZNF609 |
lung cancer |
ZNF609 |
miR-142-3p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circ_0000615 |
diabetic retinopathy |
ZNF609 |
miR-646 |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
Circ-ZNF609 |
urinary bladder carcinoma |
ZNF609 |
miR-1200 |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
CircZNF609 |
diabetic retinopathy |
ZNF609 |
miR-150-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
atherosclerosis |
ZNF609 |
miR-135b |
Q
| DN |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
CircZNF609 |
urinary bladder carcinoma |
ZNF609 |
- |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
ZNF609 |
diabetes mellitus |
ZNF609 |
miR-483-3p |
Q
S
| DN |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
thyroid cancer |
ZNF609 |
miR-514a-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
CircZNF609 / circRNA ZNF609 |
laryngeal squamous cell carcinoma |
ZNF609 |
miR-134-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
- |
HIV infectious disease |
ZNF609 |
hsa-miR-26b-3p, hsa-miR-149-5p |
S
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
melanoma |
ZNF609 |
- |
Q
M
| DN |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circZNF609 / circ-ZNF609 |
myocardial infarction |
ZNF609 |
hsa-miR-644a, hsa-miR-4303, hsa-miR-221-5p, hsa-miR-1260b, hsa-miR-1247-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
Circ-ZNF609 / hsa_circ_000193 |
esophageal squamous cell carcinoma |
ZNF609 |
miR-150-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circZNF609 / circ0000615 |
glioblastoma |
ZNF609 |
miR-145-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
acute myeloid leukemia |
ZNF609 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circZNF609 |
ovarian cancer |
ZNF609 |
miR-324-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
plasma cell myeloma |
ZNF609 |
- |
S
| UN |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 / circular RNA-ZNF609 |
coronary artery disorder |
ZNF609 |
hsa-miR-15a, hsa-miR-15b, hsa-miR-16 |
M
| UN |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
ischemic stroke |
ZNF609 |
- |
Q
| UN |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circZfp609circZNF609 |
amyotrophic lateral sclerosis |
Zfp609/ZNF609 |
- |
Q
| DS |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
chronic lymphocytic leukemia/small lymphocytic lymphoma |
ZNF609 |
- |
S
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circZNF609 |
Ewing sarcoma |
ZNF609 |
miR-145-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circRNA ZNF609 / circ-ZNF609 |
renal cell carcinoma |
ZNF609 |
miR-138-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
cZNF609 / circZNF609 |
inflammatory disease |
ZNF609 |
miR-184 |
Q
M
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
prostate cancer |
ZNF609 |
miR-186-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
CircZNF609 |
glioma |
ZNF609 |
miR-134-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
Circular RNA-ZNF609 / cZNF609 |
corneal neovascularization |
ZNF609 |
miR-184 |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
Circ-ZNF609 |
colorectal cancer |
ZNF609 |
microRNA-150, Has-miR-150-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circular RNA ZNF609 / circ-ZNF609 |
nasopharyngeal carcinoma |
ZNF609 |
microRNA-150-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
Circ-ZNF609 / circular RNA ZNF609 |
gastric cancer |
ZNF609 |
miRNA-145-5p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circ_0000615 / circRNA ZNF609 |
nasopharyngeal carcinoma |
ZNF609 |
miR-338-3p |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
colorectal cancer |
ZNF609 |
- |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
- |
lung adenocarcinoma |
ZNF609 |
- |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
diffuse large B-cell lymphoma |
ZNF609 |
miR•153 |
Q
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
acute kidney injury |
ZNF609 |
- |
Q
H
S
| UP |
More |
| Human |
hsa_circ_ZNF609 |
- |
circZNF609 |
myelodysplastic syndrome |
ZNF609 |
- |
S
| UP |
More |